Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

C. Faivre-Finn; D. R. Spigel; S. Senan; C. J. Langer; D. Raben; B. Perez; M. Ozguroglu; D. Daniel; A. Villegas; D. Vicente; R. Hui; S. Murakami; L. Paz-Ares; L. Poole; C. Wadsworth; P. A. Dennis; S. J. Antonia

Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

C. Faivre-Finn, D. R. Spigel, S. Senan, C. J. Langer, D. Raben, B. Perez, M. Ozguroglu, D. Daniel, A. Villegas, D. Vicente, R. Hui, S. Murakami, L. Paz-Ares, L. Poole, C. Wadsworth, P. A. Dennis, S. J. Antonia

Radiation Oncology (VUmc)

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	488-488
Journal	Annals of Oncology
Volume	29
Publication status	Published - Oct 2018

Cite this

Faivre-Finn, C., Spigel, D. R., Senan, S., Langer, C. J., Raben, D., Perez, B., Ozguroglu, M., Daniel, D., Villegas, A., Vicente, D., Hui, R., Murakami, S., Paz-Ares, L., Poole, L., Wadsworth, C., Dennis, P. A., & Antonia, S. J. (2018). Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC. Annals of Oncology, 29, 488-488.

@article{ec169e62e6434a71b18877c41d6474f6,

title = "Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC",

author = "C. Faivre-Finn and Spigel, {D. R.} and S. Senan and Langer, {C. J.} and D. Raben and B. Perez and M. Ozguroglu and D. Daniel and A. Villegas and D. Vicente and R. Hui and S. Murakami and L. Paz-Ares and L. Poole and C. Wadsworth and Dennis, {P. A.} and Antonia, {S. J.}",

year = "2018",

month = oct,

language = "English",

volume = "29",

pages = "488--488",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Faivre-Finn, C, Spigel, DR, Senan, S, Langer, CJ, Raben, D, Perez, B, Ozguroglu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Paz-Ares, L, Poole, L, Wadsworth, C, Dennis, PA & Antonia, SJ 2018, 'Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC', Annals of Oncology, vol. 29, pp. 488-488.

TY - JOUR

T1 - Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

AU - Faivre-Finn, C.

AU - Spigel, D. R.

AU - Senan, S.

AU - Langer, C. J.

AU - Raben, D.

AU - Perez, B.

AU - Ozguroglu, M.

AU - Daniel, D.

AU - Villegas, A.

AU - Vicente, D.

AU - Hui, R.

AU - Murakami, S.

AU - Paz-Ares, L.

AU - Poole, L.

AU - Wadsworth, C.

AU - Dennis, P. A.

AU - Antonia, S. J.

PY - 2018/10

Y1 - 2018/10

M3 - Meeting Abstract

SN - 0923-7534

VL - 29

SP - 488

EP - 488

JO - Annals of Oncology

JF - Annals of Oncology

ER -